https://orcid.org/0000-0002-3913-9048
References
- Blagodatski A, Yatsunskaya M, Mikhailova V, Tiasto V, Kagansky A, Katanaev VL. 2018. Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy. Oncotarget. 9(49):29259–29274.
- Choi YJ, Park IS, Kim MH, Kwon B, Choo YM, Jeong SI, Yu KY, Choe CH, Kim J. 2019. The medicinal mushroom Auricularia auricula-judae (Bull.) extract has antioxidant activity and promotes procollagen biosynthesis in HaCaT cells. Nat Prod Res. 33(22):3283–3286.
- De Furia MD. 1997. Paclitaxel (Taxol®): a new natural product with major anticancer activity. Phytomedicine. 4(3):273–282.
- Debnath S, Kanakaraju M, Islam M, Yeeravalli R, Sen D, Das A. 2019. In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents. Comput Biol Chem. 83:107156.
- El-Azab AS, Al-Omar MA, Abdel-Aziz AA, Abdel-Aziz NI, el-Sayed MA, Aleisa AM, Sayed-Ahmed MM, Abdel-Hamide SG. 2010. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. Eur J Med Chem. 45(9):4188–4198.
- Gangjee A, Zhao Y, Raghavan S, Ihnat MA, Disch BC. 2010. Design, synthesis and evaluation of 2-amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors and antiangiogenic agents. Bioorg Med Chem. 18(14):5261–5273.
- Kolibaba KS, Druker BJ. 1997. Protein tyrosine kinases and cancer. Biochim Biophys Acta. 1333(3):F217–F248.
- La Motta C, Sartini S, Tuccinardi T, Nerini E, Da Settimo F, Martinelli A. 2009. Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies. J Med Chem. 52(4):964–975.
- Li DD, Wu TT, Yu P, Wang ZZ, Xiao W, Jiang Y, Zhao LG. 2020. Molecular dynamics analysis of binding sites of epidermal growth factor receptor kinase inhibitors. ACS Omega. 5(26):16307–16314.
- Lindequist U, Niedermeyer TH, Jülich WD. 2005. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2(3):285–299.
- Manupati K, Dhoke NR, Debnath T, Yeeravalli R, Guguloth K, Saeidpour S, De UC, Debnath S, Das A. 2017. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs. FEBS J. 284(12):1830–1854.
- Öztürk M, Tel-Çayan G, Muhammad A, Terzioğlu P, Duru ME. 2015. Chapter 10: Mushrooms: a source of exciting bioactive compounds. In: Studies in natural products chemistry. Vol. 45; Elsevier BV, p. 363–456. Amsterdam in the Netherlands.
- Pandya U, Dhuldhaj U, Sahay NS. 2019. Bioactive mushroom polysaccharides as antitumor: an overview. Nat Prod Res. 33(18):2668–2680.
- Pasha FA, Muddassar M, Srivastava AK, Cho SJ. 2010. In silico QSAR studies of anilinoquinolines as EGFR inhibitors. J Mol Model. 16(2):263–277.
- Paterson I, Anderson EA. 2005. Chemistry. The renaissance of natural products as drug candidates. Science. 310(5747):451–453.
- Shin A, Kim J, Lim SY, Kim G, Sung MK, Lee ES, Ro J. 2010. Dietary mushroom intake and the risk of breast cancer based on hormone receptor status. Nutr Cancer. 62(4):476–483.
- Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 235(4785):177–182.
- Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 244(4905):707–712.
- Vamanu E. 2018. Bioactive capacity of some Romanian wild edible mushrooms consumed mainly by local communities. Nat Prod Res. 32(4):440–443.
- Vascellari S, Zucca P, Perra D, Serra A, Piras A, Rescigno A. 2019. Antiproliferative and antiviral activity of methanolic extracts from Sardinian Maltese Mushroom (Cynomorium coccineum L.). Nat Prod Res. 17:1–5.
- Venditto VJ, Simanek EE. 2010. Cancer therapies utilizing the camptothecins: a review of the in vivo literature. Mol Pharm. 7(2):307–349.
- Yuan JW, Wang SF, Luo ZL, Qiu HY, Wang PF, Zhang X, Yang YA, Yin Y, Zhang F, Zhu HL. 2014. Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents. Bioorg Med Chem Lett. 24(10):2324–2328.